UgHerald provides the most timely and comprehensive news coverage of Uganda. It covers a wide range of fields including politics, economy, society, culture, sports, as well as in-depth analysis of international relations and important domestic events. Whether you are concerned about local developments or international influences, this is the best source for the latest information on Uganda. We are committed to helping readers understand the current situation and future of Uganda through accurate, objective and in-depth news reports, while paying attention to the challenges and development opportunities it faces.

About Us

tanzania times : Latest News and In-depth Analysis
Contact Us

Wildlife

HomeWildlife

All News

Feb 6, 2025

CGTN: China's Spring Festival holiday box office set historic record

BEIJING,Feb. 5,2025-- In a record-breaking achievement for China\'s film industry,as of 13:29 on February 5,2025,the total box-office revenue of new films released during the 2025 Spring Festival holi

Feb 6, 2025

IBM Study: Gen AI Will Elevate Financial Performance of Banks in 2025

Initiatives are maturing from pilots and proofs of concept to targeted,enterprise-wide strategies ARMONK,N.Y.,Feb. 5,2025-- IBM (NYSE: IBM) today released its annual expectations for technology and tr

Feb 6, 2025

Leading the new trend of financial technology: the mission and vision of Global-Assets INC

Jan 26, 2025

Akkodis Named 'Enterprise Innovator' in HFS Horizons Sustainability Services, 2024 Report

The study underscores Akkodis\' integration of AI across its sustainability solutions and the incorporation of diversity and inclusion into its business model as key differentiators.

Jan 26, 2025

ChipMOS ANNOUNCES NT$350 MILLION SHARE REPURCHASE PROGRAM

HSINCHU,Jan. 21,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider of

Jan 26, 2025

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity,supporting

1 ... 89 90 91 92 93 94 95 ... 114